Clin2
NCT07164950Likely a fitRecruiting

Compression stockings to prevent nerve damage from ADC therapy

Urothelial CarcinomaAdvanced Solid TumorsChemotherapy-Induced Peripheral NeuropathyAntibody-drug Conjugates

Part of Cancer clinical trials.

This trial tests whether wearing compression stockings can help prevent nerve damage (peripheral neuropathy) caused by a type of chemotherapy called antibody-drug conjugate (ADC) in people with advanced cancers like bladder cancer. If you are starting treatment with an ADC and don't have existing nerve problems, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
58 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 or older with an advanced cancer (such as bladder cancer) that will be treated with a specific type of ADC drug (like EV, DV, or BV).
  • You have no or very mild nerve damage (peripheral neuropathy) symptoms before starting the trial.
  • You haven't taken other nerve-damaging drugs in the past 2 months.
  • Your cancer is stable and you are expected to live at least 3 more months.
  • You are willing to follow the study plan and can provide written consent.
  • You do not have severe diabetes, poor circulation, nerve compression disorders, or other serious health issues listed in the exclusion criteria.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07662863Not yet recruiting· Phase 2
New Drug vs Similar Drugs for Advanced Bladder Cancer

This study compares a new antibody-drug conjugate (sacituzumab tirumotecan) to other similar drugs for advanced bladder cancer that hasn't responded to prior treatment. It aims to see which is more effective and safe.

Shanghai, Shanghai Municipality
NCT07064798Recruiting
Cooling gloves and socks for nerve pain from chemo

This trial tests if wearing special cooling gloves and socks during chemotherapy can help prevent nerve damage, tingling, or numbness in your hands and feet. It is for people with breast or gynecologic cancer who are starting certain types of chemo that can cause these side effects.

Boston, Massachusetts
NCT06139458Recruiting
Cooling therapy to prevent nerve damage from chemo

This trial tests if cooling sleeves and gloves during chemotherapy can help prevent nerve damage (peripheral neuropathy) in people with gynecologic cancers. If you are receiving a common chemo drug called paclitaxel, this approach might reduce side effects like numbness or pain in your hands and feet.

Hartford, Connecticut
NCT07638774Recruiting
Compression Gloves and Socks to Prevent Nerve Damage from UTD1 Cancer Drug

This study tests whether wearing special compression and cooling gloves and socks can help prevent nerve damage (numbness and tingling in hands and feet) that sometimes occurs in women receiving a breast cancer medication called UTD1. You would wear these gloves and socks during and after your chemotherapy treatment.

Shanghai
NCT06551051Recruiting· Phase 2
Duloxetine for nerve damage from ADC cancer treatment

This trial tests whether duloxetine, a medicine often used for nerve pain, can help people whose nerves have been damaged by a type of cancer treatment called an antibody-drug conjugate (ADC). If you have had this side effect and it has not gone away, this study may offer a way to manage it.

Shanghai, Shanghai Municipality
NCT07464769Not yet recruiting
Compression therapy to prevent nerve damage from chemo

This trial tests if wearing compression gloves and socks during chemotherapy can prevent nerve damage in hands and feet caused by taxane or oxaliplatin treatment. It may help patients avoid numbness, tingling, or pain.

Jönköping

Hear when a new Urothelial Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.